1990 Pharm.D., University of Illinois at Chicago
1986 Pre-Pharmacy, Loyola University Chicago
PHRM 832, Introduction to Diagnosis, Labs and Monitoring
PHRM 403, 404, Integrated Laboratories
PHRM 861 Professional Program Laboratories
PHRM 865, Integrated Therapeutics
PHRM 880, Purdue APPE Rotation
CLPH 872, 873, Pathophysiology and Therapeutics II
Dr. Aziz Outstanding Teaching Award
Mayoral and Marion County Public Health Department Certificate of Appreciation in Recognition for Outstanding Contributions During the 2009-2010 H1N1 Flu Outbreak
Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy Award
Faculty Preceptor of the Year Award
1. Chung EK, Beeler CB, Muloma EW, Osterholzer D, Damer KM, Erdman, SM. Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) program. Am J Health-Syst Pharm 2016;73(1):e24-33.
2. Conant M, Erdman S, Osterholzer D. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): Clinical and economic outcome of averted cases. J Antimicrob Chemother 2014; doi: 10.1093/jac/dku015.
3. Conant M, Erdman S, Osterholzer D. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): Clinical and economic outcome of averted cases. J Antimicrob Chemother 2014; doi: 10.1093/jac/dku015.
4. Pence LM, Mock CM, Kays MB, Atkinson KM, Muloma EW, Erdman, SM. Treatment of diabetic foot infections in patients receiving outpatient parenteral antimicrobial therapy: Adherence to 2012 Infectious Diseases Society of America diabetic foot infection guideline recommendations. Diabetic Medicine. 2014 May 13. doi: 10.1111/dme.12501. [Epub ahead of print].
5. Roth AM, Holmes AM, Stump TE, Aalsma MC, Ackerman RT, Carney TS, Katz BP, Kesterson J, Erdman SM, Balt CA, Inui TS. Can lay health workers promote better medical self-management by persons living with HIV? An evaluation of the Positive Choices program. Patient Counseling and Education 2012;89:184-90.
6. Erdman SM, Buckner EE, Hindler, JF. Options for treating resistant Shigella spp. infections in children. J Pediatr Pharmacol Ther 2008;13(1):29-43.
7. Pryka RD, Rodvold KA, Erdman SM. An updated comparison of drug dosing methods: Part IV: Vancomycin. Clin Pharmacokinet 1991;20:463-76.
8. Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods: Part III: Aminoglycosides. Clin Pharmacokinet 1991;20:374-88.
9. Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods: Part II: Theophylline. Clin Pharmacokinet 1991;20:280-92.
10. Pryka RD, Rodvold KA, Erdman SM. An updated comparison of drug dosing methods: Part I: Phenytoin. Clin Pharmacokinet 1991;20:209-17.